364 related articles for article (PubMed ID: 11017819)
1. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
3. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
4. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Stenotrophomonas maltophilia bacteremia in children.
Furuichi M; Ito K; Miyairi I
Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084
[TBL] [Abstract][Full Text] [Related]
6. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
Sattler CA; Mason EO; Kaplan SL
Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
[TBL] [Abstract][Full Text] [Related]
7. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
Calza L; Manfredi R; Chiodo F
Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
[TBL] [Abstract][Full Text] [Related]
8. Attributable mortality of Stenotrophomonas maltophilia bacteremia.
Senol E; DesJardin J; Stark PC; Barefoot L; Snydman DR
Clin Infect Dis; 2002 Jun; 34(12):1653-6. PubMed ID: 12032905
[TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes.
Tan CK; Liaw SJ; Yu CJ; Teng LJ; Hsueh PR
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):205-10. PubMed ID: 17950557
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia bacteremia in burn patients.
Tsai WP; Chen CL; Ko WC; Pan SC
Burns; 2006 Mar; 32(2):155-8. PubMed ID: 16448762
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
Garazi M; Singer C; Tai J; Ginocchio CC
J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
[TBL] [Abstract][Full Text] [Related]
12. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.
Boktour M; Hanna H; Ansari S; Bahna B; Hachem R; Tarrand J; Rolston K; Safdar A; Raad I
Cancer; 2006 May; 106(9):1967-73. PubMed ID: 16565968
[TBL] [Abstract][Full Text] [Related]
13. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients.
Lai CH; Wong WW; Chin C; Huang CK; Lin HH; Chen WF; Yu KW; Liu CY
Clin Microbiol Infect; 2006 Oct; 12(10):986-91. PubMed ID: 16961635
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
16. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
Araoka H; Fujii T; Izutsu K; Kimura M; Nishida A; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Transpl Infect Dis; 2012 Aug; 14(4):355-63. PubMed ID: 22283869
[TBL] [Abstract][Full Text] [Related]
17. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
Nazik H; Ongen B; Erturan Z; Salcioğlu M
Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
[No Abstract] [Full Text] [Related]
19. Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections.
Chang YT; Lin CY; Lu PL; Lai CC; Chen TC; Chen CY; Wu DC; Wang TP; Lin CM; Lin WR; Chen YH
J Microbiol Immunol Infect; 2014 Feb; 47(1):28-35. PubMed ID: 23040236
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.
Ansari SR; Hanna H; Hachem R; Jiang Y; Rolston K; Raad I
Cancer; 2007 Jun; 109(12):2615-22. PubMed ID: 17487860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
